Browse

IMPACT OF SMOKING HISTORY ON LOCOREGIONAL RECURRENCE-FREE, DISTANT METASTASIS-FREE SURVIVAL AND OVERALL SURVIVAL IN HUMAN PAPILLOMAVIRUS (HPV)-ASSOCIATED OROPHARYNGEAL CANCER (OPC) TREATED WITH DEFINITIVE (CHEMO)RADIOTHERAPY

Pharynx / Larynx Cancer

Howard Liu¹, Anne Bernard², Elizabeth Brown¹, Laura Tam¹, Matthew Foote¹, Rob Milne², Margaret McGrath¹, Reza Rahbari¹, Bena Cartmill¹, Ben Panizza¹, Sandro Porceddu¹

¹Princess Alexandra Hospital, ²University of Queensland

QUALITY OF LIFE AFTER SUPRACRICOID PARTIAL LARYNGECTOMY

Pharynx / Larynx Cancer

Julia V Boas, Lucas Porto M Dias, Lucas R Tenorio, MD, Leandro Augusto B Silva, MD, Antonio J Goncalves, PhD

Irmandade da Santa Casa de Misericórdia de São Paulo

HPV STATUS IS NOT ASSOCIATED WITH BETTER SURVIVAL RATES IN LOW-PREVALENCE HPV INFECTION GEOGRAFIC REGIONS

Pharynx / Larynx Cancer

Rafael De Cicco, MD¹, Rosilene M Menezes, MD, PhD², Ulisses R Nicolau, MD, PhD¹, Clovis A Pinto, Md, PhD¹, Luiza L Villa, PhD³, Luiz P Kowalski, MD, PhD¹

¹AC Camargo Cancer Center, ²Hospital do Servidor Publico Municipal, ³Instituto do Cancer do Estado de São Paulo

PREOPERATIVE PREDICTORS OF DIFFICULT HYPOPHARYNGEAL EXPOSURE DURING TRANSORAL SURGERY

Pharynx / Larynx Cancer

Kazunori Fujiwara, MD, PhD, Takahiro Fukuhara, MD, PhD, Satoshi Koyama, MD, PhD, Ryohei Donishi, MD, Hiromi Takeuchi, MD, PhD

Tottori University

FIRST LINE SURGICAL TREATMENT OF OROPHARYNGEAL CARCINOMA WITH TRANS-ORAL ROBOTIC SURGERY (TORS): REVIEW OF A SINGLE INSTITUTIONS OUTCOMES

Pharynx / Larynx Cancer

Brett Leavers, Dr, Richard M Gallagher

St Vincent's Hospital Sydney

INITIALLY-POSITIVE MARGINS PREDICT WORSE SURVIVAL IN PRIMARY, BUT NOT SALVAGE, TOTAL LARYNGECTOMY

Pharynx / Larynx Cancer

Patrick Tassone, MD, Corey Savard, Michael Topf, MD, William Keane, MD, Adam Luginbuhl, MD, Joseph Curry, MD, David Cognetti, MD

Thomas Jefferson University

THE EXTENT OF NECK DISSECTION AMONG PATIENTS WHO RECEIVE ADJUVANT RADIOTHERAPY FOR HEAD AND NECK SQUAMOUS CELL CARCINOMA AND ITS EFFECT ON DISEASE- SPECIFIC AND OVERALL SURVIVAL.

Pharynx / Larynx Cancer

Usama Aboelkheir, MD, Austin Iovoli, BS, Alexis Platek, BS, Mary Platek, PhD, Anurag Singh, MD, Vishal Gupta, MD, David Cohan, MD, Wesley Hicks, MD, Hassan Arshad, MD

Roswell Park Cancer Institute

PREDICTORS OF SWALLOW FUNCTION AFTER TRANSORAL SURGERY FOR LOCALLY ADVANCED OROPHARYNGEAL CANCER

Pharynx / Larynx Cancer

Jennifer Gross, MD¹, Melanie Townsend, MD¹, Joseph Zenga, MD², Ryan Jackson, MD¹, Bruce Haughey, MD, FACS³, Jason Rich, MD¹

¹Washington University Department of Otolaryngology, ²Massachusetts Eye and Ear Infirmary, ³Florida ENT Surgical Specialists

COMPARING MUTATIONAL PROFILES OF RESPONDERS AND NON-RESPONDERS CELL-FREE CIRCULATING TUMOR DNA IN OROPHARYNGEAL SQUAMOUS CELL CARCINOMA PATIENTS

Pharynx / Larynx Cancer

Mickie J Hamiter, MD¹, Adam H Greer, PhD², Rhett Orgeron¹, Alok R Khandelwal, PhD¹, Xiaohui Ma¹, Tara Moore-Medlin¹, Hong Yin, MDPhD², Glenn Mills, MD², Cherie-Ann O Nathan, MD¹

¹LSU Health Shreveport, ²Feist Weiller Cancer Center

LARYNGEAL CANCER TREATMENT AND OUTCOMES IN THE UNDER AND UNINSURED: A 10 YEAR REVIEW

Pharynx / Larynx Cancer

Tanner M Fullmer, MD, David M Wilde, Susan A Eicher, MD, Nadia G Mohyuddin, MD, Andrew G Sikora, MD, PhD, Vlad C Sandulache, MD, PhD

Baylor College of Medicine Bobby R. Alford Department of Otolaryngology